20/05/2013

Actavis buying Warner Chilcott in $8.5B deal

Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.

Breakthrough calls time on bootleg booze

(Phys.org) —Using a laser, the St Andrews scientists can now carry out detailed analysis of a spirit sample no bigger than a teardrop and can even confirm whether it is toxic or not. It's hoped the testing breakthrough ...

Explainer: What are stem cells?

In a paper published in Cell yesterday, scientists from the US and Thailand have, for the first time, successfully produced embryonic stem cells from human skin cells.

AP probe further strains Obama, press rapport

Reports emerged last week that the Department of Justice had secretly obtained two months' worth of phone records of journalists at The Associated Press as part of a larger investigation into a failed al-Qaida plot. The news ...

page 6 from 9